How much does a fasting insulin test cost? A fasting insulin draw commonly costs $15 to $100 as a self-pay test, depending on the lab and the market. The price is small and the clinical value is large. It is one of the least expensive tests in medicine and one of the most informative for anyone whose weight, A1c or energy has been drifting while their labs were called normal. What the price does not buy is a clinician who reads the result against your history and acts on it.

Key Takeaways
  • A fasting insulin test commonly costs $15 to $100 as a self-pay draw.
  • It is meaningful only as a fasting draw and is read beside a fasting glucose for the insulin-resistance picture.
  • Insulin resistance often shows in fasting insulin years before A1c moves, which is why it belongs on a quarterly panel for the right patient.
  • GoodLife Health includes fasting insulin in the Biomarker Audit every 90 days inside the $299/month membership.
  • Additional labs beyond the quarterly cadence are ordered by the clinician when there is a reason and billed by the lab at its own rates.

How much does a fasting insulin test cost?

The test itself is inexpensive because the assay is routine and widely available. The spread between $15 and $100 comes from three things: the lab you choose, the market you are in and whether the draw fee is billed separately from the test. Some labs bundle the draw into the quoted price and some bill it as a separate line item, so ask for the complete self-pay figure before you book.

Fasting insulin test cost breakdown

What you're paying for

ComponentWhat it coversTypical self-pay range
Fasting insulin assayThe insulin measurement on one blood drawAbout $15 to $100
Fasting glucose (ordered beside it)The sugar value that makes insulin interpretableAbout $10 to $50
Draw and processing feeCollection, handling and shippingAbout $10 to $50
InterpretationA clinician who reads insulin with glucose, symptoms and historyUsually billed separately

Why the test is read in pairs

Insulin makes sense only beside the glucose it is managing. A high fasting insulin with a normal fasting glucose describes compensation and is the earliest measurable sign of insulin resistance. A high insulin with a rising glucose describes a system losing the fight. A fasting insulin test ordered alone gives you half the story, so a clinician who orders the pair does the complete job.

Your clinician can also calculate HOMA-IR, a computed insulin-resistance index, from the two fasting values on the same panel without an additional test.

Clinical note

A high fasting insulin with a normal fasting glucose describes compensation and is the earliest measurable sign of insulin resistance. A high insulin with a rising glucose describes a system losing the fight.

What moves the price up or down

  • The lab and the market: the same assay varies by region and provider network.
  • Whether the draw fee is inside the quoted price or billed separately.
  • Whether the clinician orders fasting glucose, A1c and related markers on the same draw, which costs more individually and tells you more together.
  • Whether you are buying a single test or a panel, because a standalone purchase carries the full draw overhead on one marker.
GoodLife Health. Labs, clinician, medicine, platform, $299 a month: quarterly labs, your clinician, guided GLP-1s, your data in one place. Check eligibility.GoodLife Health. Your labs, your clinician, your medicine, your data. One place. Comprehensive labs every 90 days, a board-certified clinician, branded GLP-1s when indicated, and a platform that holds it all, $299 a month. Check your eligibility.

What a one-off draw cannot tell you

A single fasting insulin value is a snapshot. What makes the marker powerful is a trend: the same test every 90 days, read by the same clinician, against the same history, tells you whether the number is moving with your weight, your diet and your medications or against them. This is the gap the Stability-Seeking High-Dose Patient feels most keenly, because the prescriber who adjusts their GLP-1 dose each month has often never drawn a fasting insulin at all.

If your A1c has been creeping while your weight stalls, our guide on why an A1c creeps up covers the same insulin-resistance story from the glucose side.

The math of tracking insulin resistance

Four fasting insulin draws a year, bought one at a time, commonly cost $60 to $400 before the glucose values and the clinical review that make them useful. Our membership is $299 a month and the quarterly Biomarker Audit includes Fasting Insulin alongside Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP, Hemoglobin A1c (HbA1c), Lipid Panel, Standard, TSH With Reflex To Free T4 and more. Labs are drawn at any Quest patient service center. Additional labs beyond the quarterly cadence are billed to the patient at pass-through cost.

The fee covers the clinicians, the quarterly labs, every result in your hands, messaging with the care team, video visits and your own health platform, where every lab, visit and medication builds into one Health Story with Cassandra to help you understand your numbers. It does not cover medication. Medication, when your clinician prescribes it, is billed separately by the pharmacy at pharmacy cost with zero markup from us. One flat fee for the doctor. Zero markup on the medicine.

What the numbers show
$15 to $100
Self-pay cost of a single fasting insulin draw
$60 to $400
Cost of four draws a year bought one at a time
$299/mo
Cardiometabolic Optimization Membership, quarterly Biomarker Audit included
90 days
Frequency of fasting insulin testing in the Biomarker Audit

What happens after the draw

An elevated fasting insulin on our panel goes to a clinician who can order confirmatory testing, adjust a plan and, where appropriate, prescribe branded FDA-approved GLP-1 medication when it is clinically indicated. Our GLP-1 is branded and FDA-approved, never compounded. Medication is billed by the pharmacy at that pharmacy's own price and the membership fee does not change when the medication or the dose changes.

If you want the visit structure laid out, our guide on what happens in your first 90 days of membership walks through it. Clinical care is delivered by board-certified physicians in all fifty states through our clinical partner.

The objections a discerning buyer raises

'It is a $25 test. Why would I pay $299 a month for it?' Because the test is not the product. The product is a clinician who draws it every quarter, reads it against your glucose and your history and acts on what it shows. Buying the marker alone buys the number and nothing else.

'My doctor says insulin is not a standard test.' It is not on a standard annual panel in many practices, which is exactly why the patients who need it go without it. If your doctor will order it and follow the trend, do that. If they will not, that is the gap a membership closes.

'Will you make me start a new medication?' No. Bring your current prescription. Labs come first, the clinician decides with you and there is no forced restart. Our clinician rule is that a GLP-1 is not automatically increased every month because a higher dose exists on the dosing schedule.

'I already do Function Health.' Then you have the number. You do not have the clinician who reads it quarterly against your A1c, your weight and your medication and prescribes when it is indicated. Bring the results and they become the baseline for your first Biomarker Audit.

FAQ

How much does a fasting insulin test cost?

A fasting insulin test commonly costs $15 to $100 as a self-pay draw. Prices move with the lab, the market and whether the draw fee is billed separately, so the complete out-of-pocket figure sits at or above the advertised price.

Is a fasting insulin test covered by insurance?

Coverage varies by plan and usually requires a recognized diagnostic reason. Tests ordered to understand insulin resistance before a diagnosis exists are frequently not covered, which is one reason self-pay readers buy this testing outside insurance.

What is HOMA-IR and why does it matter?

HOMA-IR is a calculated insulin-resistance index from fasting insulin and fasting glucose. Your clinician can calculate it from the two fasting values on your panel without an additional test.

Do I need to fast for the test?

Yes. The test is meaningful only as a fasting draw, generally 8 to 12 hours without food and your clinician should also read a fasting glucose beside it so the two numbers can be interpreted together.

How often should fasting insulin be checked?

A clinician sets the cadence based on your picture. Our Biomarker Audit includes fasting insulin every 90 days, four draws a year inside the $299/month membership.

Is a fasting insulin test the same as an A1c?

No. A1c is a three-month average of blood sugar and fasting insulin is the hormone level driving blood sugar control. Insulin resistance often shows in fasting insulin years before A1c moves, which is why clinicians who track it order both.

Does the $299 membership include fasting insulin?

Yes. The $299/month Cardiometabolic Optimization Membership includes a Biomarker Audit every 90 days and fasting insulin is part of that panel. Additional labs beyond the quarterly cadence are billed to the patient at pass-through cost.

Will a high fasting insulin result guarantee a GLP-1 prescription?

No. An elevated result informs a clinical decision and your clinician decides whether medication is appropriate after reviewing your history, findings and goals. Medication, when prescribed, is billed separately by the pharmacy at pharmacy cost.

One last thing

A fasting insulin value drawn once tells you where you are. Drawn every 90 days by the same clinician, it tells you where you are going.

GoodLife Health

A fasting insulin value drawn once tells you where you are. Drawn every 90 days by the same clinician, it tells you where you are going. That is the difference between a lab result and a care plan and it is the part of the bill no one-off quote includes.

Related Guides

References

  1. Standards of Care in Diabetes: Classification and Diagnosis of Diabetes (American Diabetes Association, 2026). 2026. diabetesjournals.org/care/article/49/S1/S20/S161478